Cecilia Nalli

COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study

Micaela Fredi, Ilaria Cavazzana, Liala Moschetti et al. · The Lancet Rheumatology · 2020 · 146 citations · Full text

Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry.

Luca Iaccarino, Elena Bartoloni, Linda Carli et al. · PubMed · 2015 · 109 citations

Clinical Characterization of Antiphospholipid Syndrome by Detection of IgG Antibodies Against β ₂ ‐Glycoprotein I Domain 1 and Domain 4/5: Ratio of Anti–Domain 1 to Anti–Domain 4/5 As a Useful New Biomarker for Antiphospholipid Syndrome

Laura Andréoli, Cecilia Beatrice Chighizola, Cecilia Nalli et al. · Arthritis & Rheumatology · 2015 · 103 citations

Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry

Jaume Alijotas‐Reig, Enrique Esteve‐Valverde, Raquel Ferrer‐Oliveras et al. · Lara D. Veeken · 2019 · 94 citations · Full text

Anti-β2-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their ‘innocent’ profile?

Laura Andréoli, Cecilia Nalli, Mario Motta et al. · Annals of the Rheumatic Diseases · 2010 · 89 citations